The production volumes of chemical and pharmaceutical products in Sweden have shown fluctuations over the past decade. From 2013 to 2023, there were periods of growth and decline, highlighted by significant increases in 2019 and 2021. However, the market exhibited a downturn in 2020, followed by a robust recovery in 2021. The year 2023 marked a slight increase to 190.47 Billion Swedish Kronas, continuing a general upward trend post-2020.
Key variations observed over the past two years included a slight decrease in 2022 and a modest increase in 2023. The Compound Annual Growth Rate (CAGR) over the last five years is positive, indicating an average annual growth of 3.19%.
Future trends to watch for include the anticipated steady growth from 2024 to 2028, with forecasts pointing to an incremental rise leading to a CAGR of 0.97% and an overall growth rate of 4.95% over five years. This suggests a stable but cautious optimism for the industry, driven by advancements in pharmaceutical innovation and sustainable chemical production practices.
